Cape Investment Advisory’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$342K Buy
2,665
+251
+10% +$29.4K 0.09% 167
2026
Q1
$290K Buy
2,414
+1,478
+158% +$171K 0.1% 178
2025
Q4
$98.5K Buy
936
+435
+87% +$40.8K 0.03% 306
2025
Q3
$42K Sell
501
-650
-56% -$53.5K 0.04% 243
2025
Q2
$91.1K Sell
1,151
-106
-8% -$8.43K 0.03% 281
2025
Q1
$113K Sell
1,257
-98
-7% -$9.15K 0.04% 230
2024
Q4
$135K Buy
1,355
+419
+45% +$43.2K 0.05% 214
2024
Q3
$106K Buy
936
+1
+0.1% +$119 0.04% 227
2024
Q2
$116K Buy
935
+1
+0.1% +$129 0.05% 216
2024
Q1
$123K Sell
934
-127
-12% -$15.7K 0.06% 194
2023
Q4
$116K Buy
1,061
+59
+6% +$6.12K 0.06% 205
2023
Q3
$103K Sell
1,002
-24
-2% -$2.59K 0.06% 207
2023
Q2
$118K Buy
1,026
+1
+0.1% +$114 0.07% 184
2023
Q1
$109K Buy
+1,025
New +$111K 0.07% 184

Other funds holding MRK

Cape Investment Advisory's MRK Position: Q2 2026 in Review

Cape Investment Advisory increased its Merck (MRK) stake by 10% in Q2 2026, buying an estimated $29.4K and bringing the position to 2,665 shares worth $342K. The position accounts for 0.09% of the portfolio, ranked #167.

Cape Investment Advisory first reported a position in MRK in Q1 2023 and has held it in 14 quarters since. 1,752 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Cape Investment Advisory held 2,665 shares of Merck worth $342K as of Q2 2026.
  • Cape Investment Advisory bought 251 Merck shares in Q2 2026, an estimated $29.4K.
  • Merck made up 0.09% of Cape Investment Advisory's portfolio in Q2 2026, its #167 holding.
  • Cape Investment Advisory first reported a position in Merck in Q1 2023 and has held it in 14 quarters since.
  • 1,752 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Cape Investment Advisory's 13F filing for Q2 2026, filed 23 Jul 2026.